Alopecia Areata study: VC005 tablets
Official title A Phase I Study of VC005 Tablets in Adolescent Subjects With Severe Alopecia Areata
ClinicalTrials.gov ID: NCT07762443
What this study is testing
What is VC005 tablets?
VC005 tablets is an investigational medicine, taken by mouth, being studied as a potential treatment for alopecia areata.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study is a non-dose-finding Phase I study designed to look at the pharmacokinetics (PK), safety, and preliminary how well it works of VC005 tablets in adolescent people with severe alopecia areata (AA).
- Phase 1: an early, usually small safety study
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 12 to 18
You may be able to join if
- The subject fully understands this study and is able to comply with the relevant trial procedures.
- Age 12 to 18 years inclusive (including 12 years old, excluding 18 years old) at the time of signing the ICF, both genders, with body weight ≥ 40 kg.
- people must meet the diagnostic criteria for alopecia areata (AA) at both screening and baseline visits.
You likely can't join if
- Women who are pregnant or breastfeeding, or people who plan to become pregnant or breastfeed during the study period.
- people with a current diagnosis of acute diffuse alopecia areata (AA).
- people with a current diagnosis of other types of alopecia that may interfere with the evaluation of AA, including but not limited to traction...
- people with other scalp diseases that may affect the assessment of AA, such as scalp psoriasis, dermatitis, tinea capitis, etc.
The study team makes the final eligibility decision.
Where it is enrolling
- Beijing, Beijing Municipality, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 12 years to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Beijing, Beijing Municipality, China. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.